Samsung Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Samsung Pharmaceutical Co Ltd with three other
companies in this sector in South Korea:
Sinil Pharmaceutical Co Ltd
sales of 44.70 billion Korean Won [US$37.77 million]
Humedix Co Ltd
(42.13 billion Korean Won [US$35.60 million]
Schnell Biopharmaceuticals Incorporation
(40.32 billion Korean Won [US$34.07 million]
During the year ended December of 2015, sales at
Samsung Pharmaceutical Co Ltd were 42.16 billion Korean Won (US$35.63 million).
increase of 39.2%
versus 2014, when the company's sales were 30.29 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2013, when Samsung Pharmaceutical Co Ltd
reported sales of 46.92 billion Korean Won.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Samsung Pharmaceutical Co Ltd had sales
of 39.24 billion Korean Won.